Immuron IMRN
NASDAQ IMRN
$1.17 +0.01 (+0.86%)
As of: Oct 1, 2026 · 9:58 AM EDT

Immuron (IMRN) Notes Payables (2017 - 2019)

Updated

Immuron's Notes Payables came in at $98,120 for FY2019 (year ended Dec 31, 2019).

Analysis

Immuron (IMRN) Notes Payables (2017 - 2019) Analysis & Trends

  • Per Business Quant, earlier fiscal years put Notes Payables at $105,466 in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Immuron 9.36 Mn -7.94 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 98,120.00
Jun 30, 2017 105,067.28
API Access

Immuron Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=IMRN&period=max&api_key=YOUR_API_KEY